February 13, 2020 / 12:23 PM / 9 days ago

BRIEF-Acorda Therapeutics Posts Q4 Earnings Per Share $1.38

Feb 13 (Reuters) - Acorda Therapeutics Inc:

* ACORDA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 GAAP EARNINGS PER SHARE $1.38

* Q4 NON-GAAP LOSS PER SHARE $0.15

* Q4 EARNINGS PER SHARE ESTIMATE $-0.41 — REFINITIV IBES DATA

* ACORDA THERAPEUTICS - TOTAL PRODUCT NET REVENUE FOR FULL YEAR 2020 IS EXPECTED TO BE $120 - $150 MILLION WITH TOTAL REVENUE EXPECTED TO BE $130 - $160 MILLION

* FY2020 REVENUE VIEW $149.2 MILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below